Jaeyul Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jaeyul Choi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Young Hoon Kim
Hanmi Research Center, Hanmi Pharm. Co. Ltd., 550 Dongtangiheung-Ro, Hwaseong-Si, Gyeonggi-Do 18469, Republic of Korea
2 shared publications Bokyung Park
Department of Environmental & Health Chemistry, College of Pharmacy, Chung-Ang University, 84, Heukseok-gu, Seoul 06974, Republic of Korea
1 shared publication- Changhee Park
Hanmi Research Center, Hanmi Pharm. Co. Ltd., 550 Dongtangiheung-Ro, Hwaseong-Si, Gyeonggi-Do 18469, Republic of Korea
1 shared publication - Dae Kyong Kim
Chung-Ang University
1 shared publication Daejin Kim
Department of Environmental & Health Chemistry, College of Pharmacy, Chung-Ang University, 84, Heukseok-gu, Seoul 06974, Republic of Korea; Hanmi Research Center, Hanmi Pharm. Co. Ltd., 550 Dongtangiheung-Ro, Hwaseong-Si, Gyeonggi-Do 18469, Republic of Korea
1 shared publication- Ha Hyung Kim
Department of Global Innovative Drugs, Graduate School of Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Republic of Korea
1 shared publication
Latest Publications
- 1 February 2021
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 34, 127676
Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists
- 1 February 2021
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 34, 127676
Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists
- 1 January 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (2) , 271-275
Synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel FMS inhibitors
- 1 January 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (2) , 271-275
Synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel FMS inhibitors